Status:
COMPLETED
Role of Choline PET/CT in Predicting Survival in Patients With Hepatocellular Carcinoma
Lead Sponsor:
Humanitas Clinical and Research Center
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
¹¹C-choline positron emission tomography/computed tomography (PET/CT) has been used in patients with some types of solid cancers, but few data are available in patients undergoing hepatectomy for hepa...
Detailed Description
Our prospectively maintained liver unit database was queried for patients with HCC preoperatively staged with ¹¹C-choline PET/CT. This metabolic imaging modality was performed in addition to standard ...
Eligibility Criteria
Inclusion
- Any patient with HCC candidate to surgical resection preoperatively staged with ¹¹C-choline PET/CT
Exclusion
- R2 resection;
- Intraoperative use of RFA/MWI
- Postoperative death (90-days)
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2016
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03430635
Start Date
January 1 2010
End Date
January 31 2016
Last Update
February 13 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.